Tadalafil is a long-acting PDE5 inhibitor with 17.5-hour half-life, enabling on-demand and daily low-dose protocols. Compounded 22 mg troches (sublingual lozenges) are an industry-standard telehealth dose for as-needed erectile dysfunction, absorbed partially through oral mucosa before swallowing.
Sublingual delivery may reduce time-to-peak versus oral tablets for some patients, though compounded troches are not FDA-approved with bioequivalence data to Cialis. Effects last up to 36 hours in label language for branded product; patients should plan around nitrates (absolute contraindication) and alpha-blocker interactions.
Common side effects: headache, flushing, dyspepsia, nasal congestion. Visual disturbances are rare. CLYR Health offers tadalafil 22 mg troches as a preview sexual health SKU.